The global e-prescribing market size reached USD 2.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 13.0 Million by 2033, exhibiting a growth rate (CAGR) of 18.94% during 2025-2033. There are various factors that are driving the market, which include the rising focus on maintaining patient safety while reducing medication errors, increasing adoption of healthcare information technology, including electronic health records (EHRs), and favorable government initiatives.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033 |
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 2.7 Million |
Market Forecast in 2033
|
USD 13.0 Million |
Market Growth Rate 2025-2033
|
18.94% |
Patient Safety and Medication Error Reduction
The rising focus on enhancing patient safety while minimizing medication errors is impelling the market growth. Traditional paper-based prescriptions are susceptible to errors including illegible handwriting and incorrect dosages, which can lead to adverse drug events and compromised patient well-being. E-prescribing systems address these issues by providing clear and electronically generated prescriptions that can be easily interpreted by pharmacists and healthcare providers. These systems help prevent potentially harmful medication combinations through built-in checks for drug interactions and allergies. Furthermore, the rising focus on improving patient outcomes and overall healthcare quality is offering a favorable e-prescribing market outlook. Key players are introducing solutions that offer enhanced patient safety and satisfaction. For instance, on 21 June 2023, Telecare launched Australia’s first-ever standalone platform for e-prescriptions. It is designed to take the place of traditional paper prescription techniques. This technology is set to reshape the way healthcare can be delivered to patients. It will empower physicians and improve the patient experience, making consultations pleasant for all.
Adoption of Healthcare Information Technology (IT)
As per the research report of the IMARC Group, the global healthcare IT market reached US$ 327.9 Billion in 2023. The increasing adoption of healthcare IT like electronic health records (EHRs), along with a focus on enhanced decision-making, are providing favorable e-prescribing market insights. Prescriptions, medical histories, and patient health data are all stored in EHRs. E-prescribing systems and EHRs can work together to simplify the prescription process and give healthcare professionals access to patient medication histories so they can make informed decisions. This interoperability enhances communication between physicians, pharmacists, and patients, leading to better-coordinated care. Furthermore, the smooth interchange of prescription data lowers the possibility of duplicate prescriptions and aids medical practitioners in making knowledgeable decisions about medication administration.
Favorable Government Initiatives
Governing agencies of various countries are recognizing the importance of improving healthcare efficiency and reducing healthcare costs. They are also undertaking several initiatives in the form of financial incentives, penalties, or mandates for healthcare providers to adopt digital healthcare methods. These programs highlight major e-prescribing market growth drivers. They are aiming to standardize and streamline the prescription process by encouraging the transition from paper-based prescriptions to electronic systems. Legislators and regulatory authorities' support gives e-prescribing systems legitimacy, which promotes their increased adoption and integration in healthcare settings. They are also concentrating on keeping important patient records that they may use to provide better care. For instance, on 5 May 2023, the West Bengal health department declared e-prescriptions in all the state-run medical colleges and hospitals, district hospitals, and primary health centers to preserve patient data and their case histories.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on component, delivery mode, end user, and specialties.
Breakup by Component:
Solutions account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the component. This includes solutions and services. According to the report, solutions represented the largest segment.
The rising demand for e-prescribing solutions due to the focus on reducing medication errors is impelling the market growth. In order to guarantee accurate and secure prescriptions, these solutions include features like drug interaction checks, allergy alarms, and dose recommendations. EHRs and e-prescribing work together seamlessly to expedite the prescription process and improve communication between pharmacists and healthcare professionals. The market segment is also influenced by laws and regulations that encourage the usage of e-prescribing systems.
Breakup by Delivery Mode:
Web-based holds the largest share of the industry
A detailed breakup and analysis of the market based on the delivery mode have also been provided in the report. This includes web-based, cloud-based, and on-premises. According to the report, web-based accounts for the largest market share.
Web-based solutions allows healthcare professionals to access the system from any location with an internet connection. These solutions reduce deployment costs and complexity by just requiring minimal hardware and software installations. Furthermore, seamless integration between web-based e-prescribing systems and EHRs foster interoperability and improve prescription management. Additionally, the rising adoption of telehealth and digital healthcare solutions is impelling the market growth. As a result, these factors collectively show e-prescribing industry overview.
Breakup by End User:
Hospitals represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, pharmacies, office-based physicians, and others. According to the report, hospitals represent the largest segment.
Hospitals can manage high patient and prescription volumes. They require affordable solutions that minimize medication errors and expedite the prescription procedure. A hospital's sophisticated healthcare IT infrastructure also makes it possible for e-prescribing software to be seamlessly integrated with EHRs for effective prescription administration. Furthermore, government initiatives and mandates promoting the use of e-prescribing in healthcare facilities including hospitals assist in increasing the adoption of these systems and influencing e-prescribing market dynamics positively.
Breakup by Specialties:
Oncology exhibits a clear dominance in the market
A detailed breakup and analysis of the market based on the specialties have also been provided in the report. This includes oncology, sports medicine, neurology, cardiology, and others. According to the report, oncology accounts for the largest market share.
The growing demand for efficient and streamlined prescription management solutions in oncology due to the increasing prevalence of cancer cases worldwide is positively influencing the market. Oncology treatments often involve complex medication regimens, making e-prescribing systems crucial for reducing errors and ensuring precise drug administration. In addition, advancements in cancer research and personalized medicine are necessitating sophisticated e-prescribing tools to handle specialized prescriptions. As per the World Health Organization (WHO), around 35 million new cancer cases are predicted by 2050.
Breakup by Region:
North America leads the market, accounting for the largest e-prescribing market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for e-prescribing.
North America has a highly developed healthcare infrastructure and a strong focus on technological advancements, which creates a favorable environment for the adoption of e-prescribing systems. Moreover, favorable government initiatives in the region are propelling the market growth. These initiatives aim to improve patient safety, reduce medication errors, and enhance overall healthcare efficiency. Moreover, a well-established pharmaceutical industry and a large patient population with chronic diseases are catalyzing the demand for streamlined prescription processes. Furthermore, North America has a high level of healthcare spending that allows healthcare organizations to invest in innovative technologies. Besides this, key players in the market are engaging in partnerships and collaborations to expand their market reach. For example, on 7 June 2023, BoomerangFX partnered with health technology pioneer DrFirst to launch e-prescribing for aesthetic medicine practices across North America. It offers clients a unified medication management platform to maximize clinical workflows and patient engagement. BoomerangFX's practice management and digital marketing software platform will also integrate DrFirst's RxInform to automatically trigger a secure message to patients after their physician sends an e-prescription to the pharmacy.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Components Covered | Solutions, Services |
Delivery Modes Covered | Web-Based, Cloud-Based, On-Premises |
End Users Covered | Hospitals, Pharmacies, Office-Based Physicians, Others |
Specialties Covered | Oncology, Sports Medicine, Neurology, Cardiology, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Allscripts Healthcare Solutions Inc., Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital), Cerner Corporation, Computer Programs and Systems Inc., DrFirst.com Inc., Epic Systems Corporation, Henry Schein Inc., Medical Information Technology Inc., Nextgen Healthcare Inc., Surescripts LLC, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
We expect the global e-prescribing market to exhibit a CAGR of 18.94% during 2025-2033.
The growing adoption of e-prescription software to automatically refill prescriptions for patients and manage medications based on their recorded history, along with identifying fraudulent entries, is primarily driving the global e-prescribing market.
The sudden outbreak of the COVID-19 pandemic has led to the rising demand for cloud-based solution across the healthcare sector, such as telemedicine and telehealth solutions, as they facilitate e- prescription for providing specialized care to the patients.
Based on the component, the global e-prescribing market has been segmented into solutions and services. Currently, solutions hold the majority of the total market share.
Based on the delivery mode, the global e-prescribing market can be divided into web-based, cloud- based, and on-premises, where web-based currently exhibits a clear dominance in the market.
Based on the end user, the global e-prescribing market has been categorized into hospitals, pharmacies, office-based physicians, and others. Among these, hospitals account for the majority of the global market share.
Based on the specialties, the global e-prescribing market can be segregated into oncology, sports medicine, neurology, cardiology, and others. Currently, oncology holds the largest market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global e-prescribing market include Allscripts Healthcare Solutions Inc., Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital), Cerner Corporation, Computer Programs and Systems Inc., DrFirst.com Inc., Epic Systems Corporation, Henry Schein Inc., Medical Information Technology Inc., Nextgen Healthcare Inc., and Surescripts LLC.